GlobalData Market Research Reports
Browse All Reports of GlobalData
| Pages: « Last 1 2 3 4 5 6 7 8 9 10 Next » | Displaying 1 to 100 (of 5267 records) |
Title
Published Date
Price
Norway Gas Markets, 2013
This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Norway. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance...
This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Norway. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance...
June 2013
$2500
Cuba Gas Markets, 2013
This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Cuba. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance f...
This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Cuba. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance f...
June 2013
$2500
Peru Gas Markets, 2013
This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Peru. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand bala...
This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Peru. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand bala...
June 2013
$2500
Granite Wash Shale in the US, 2013 - Oil Shale Market Analysis and Forecasts to 2020
Granite Wash Shale in the US, 2013 - Oil Shale Market Analysis and Forecasts to 2020 Summary “Granite Wash Shale in the US, 2013 - Oil Shale Market Analysis and Forecasts to 2020”, is the latest report from GlobalData, the industry analysis specialist, which analyzes the oil shale market in the Granite Wash pla...
Granite Wash Shale in the US, 2013 - Oil Shale Market Analysis and Forecasts to 2020 Summary “Granite Wash Shale in the US, 2013 - Oil Shale Market Analysis and Forecasts to 2020”, is the latest report from GlobalData, the industry analysis specialist, which analyzes the oil shale market in the Granite Wash pla...
June 2013
$1500
Latvia Power Market Outlook to 2030 - Market Trends, Regulations and Competitive Landscape
Latvia Power Market Outlook to 2030 Market Trends, Regulations and Competitive Landscape Summary This report examines Latviias power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Latvian power markets regulatory structure, i...
Latvia Power Market Outlook to 2030 Market Trends, Regulations and Competitive Landscape Summary This report examines Latviias power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Latvian power markets regulatory structure, i...
June 2013
$1500
Estonia Power Market Outlook to 2030 - Market Trends, Regulations and Competitive Landscape
Estonia Power Market Outlook to 2030 Market Trends, Regulations and Competitive Landscape Summary This report examines Estonias power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Estonian power markets regulatory structure,...
Estonia Power Market Outlook to 2030 Market Trends, Regulations and Competitive Landscape Summary This report examines Estonias power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Estonian power markets regulatory structure,...
June 2013
$1500
Top 20 North America Independent Exploration and Production (E&P) Companies: Financial & Operational Fundamental Analysis and Benchmarking-2013
Top 20 North America Independent Exploration and Production (E&P) Companies: Financial & Operational Fundamental Analysis and Benchmarking-2013 Summary "Top 20 North America Independent Exploration and Production (E&P) Companies: Financial & Operational Fundamental Analysis and Benchmarking-2013" is t...
Top 20 North America Independent Exploration and Production (E&P) Companies: Financial & Operational Fundamental Analysis and Benchmarking-2013 Summary "Top 20 North America Independent Exploration and Production (E&P) Companies: Financial & Operational Fundamental Analysis and Benchmarking-2013" is t...
May 2013
$3995
Norway Oil Markets, 2013
Norway Oil Markets, 2013 Summary This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Norway . It details the market structure, regulatory environment, infrastructure and provides historical a...
Norway Oil Markets, 2013 Summary This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Norway . It details the market structure, regulatory environment, infrastructure and provides historical a...
May 2013
$2500
Cuba Oil Markets, 2013
Cuba Oil Markets, 2013 Summary This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Cuba. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relatin...
Cuba Oil Markets, 2013 Summary This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Cuba. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relatin...
May 2013
$2500
Peru Oil Markets, 2013
Peru Oil Markets, 2013 Summary This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Peru. It details the market structure, regulatory environment, infrastructure and provides historical and fo...
Peru Oil Markets, 2013 Summary This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Peru. It details the market structure, regulatory environment, infrastructure and provides historical and fo...
May 2013
$2500
PharmaPoint: Hepatitis C Virus - Current and Future Players
PharmaPoint: Hepatitis C Virus Current and Future Players Summary GlobalData has released its pharma report, PharmaPoint: Hepatitis C Virus Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HCV Market. The report identifie...
PharmaPoint: Hepatitis C Virus Current and Future Players Summary GlobalData has released its pharma report, PharmaPoint: Hepatitis C Virus Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HCV Market. The report identifie...
May 2013
$2995
MediPoint: Breast Cancer Imaging - APAC Analysis and Market Forecasts
MediPoint: Breast Cancer Imaging APAC Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption of wes...
MediPoint: Breast Cancer Imaging APAC Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption of wes...
May 2013
$4450
PharmaPoint: Hepatitis C Virus - United States Drug Forecast and Market Analysis
PharmaPoint: Hepatitis C Virus United States Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus United States Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic...
PharmaPoint: Hepatitis C Virus United States Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus United States Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic...
May 2013
$4995
PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis
PharmaPoint: Hepatitis C Virus France Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus France Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic prese...
PharmaPoint: Hepatitis C Virus France Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus France Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic prese...
May 2013
$4995
PharmaPoint: Hepatitis C Virus - Germany Drug Forecast and Market Analysis
PharmaPoint: Hepatitis C Virus Germany Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus Germany Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic pre...
PharmaPoint: Hepatitis C Virus Germany Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus Germany Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic pre...
May 2013
$4995
PharmaPoint: Hepatitis C Virus - Italy Drug Forecast and Market Analysis
PharmaPoint: Hepatitis C Virus Italy Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus Italy Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. T...
PharmaPoint: Hepatitis C Virus Italy Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus Italy Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. T...
May 2013
$4995
PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis
PharmaPoint: Hepatitis C Virus Spain Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus Spain Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic present...
PharmaPoint: Hepatitis C Virus Spain Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus Spain Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic present...
May 2013
$4995
PharmaPoint: Hepatitis C Virus - United Kingdom Drug Forecast and Market Analysis
PharmaPoint: Hepatitis C Virus United Kingdom Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus United Kingdom Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chron...
PharmaPoint: Hepatitis C Virus United Kingdom Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus United Kingdom Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chron...
May 2013
$4995
PharmaPoint: Hepatitis C Virus - Japan Drug Forecast and Market Analysis
PharmaPoint: Hepatitis C Virus Japan Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus Japan Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. T...
PharmaPoint: Hepatitis C Virus Japan Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus Japan Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. T...
May 2013
$4995
PharmaPoint: Hepatitis C Virus - Brazil Drug Forecast and Market Analysis
PharmaPoint: Hepatitis C Virus - Brazil Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus - Brazil Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often a...
PharmaPoint: Hepatitis C Virus - Brazil Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus - Brazil Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often a...
May 2013
$4995
PharmaPoint: Hepatitis C Virus - China Drug Forecast and Market Analysis
PharmaPoint: Hepatitis C Virus China Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus China Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. T...
PharmaPoint: Hepatitis C Virus China Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Hepatitis C Virus China Drug Forecast and Market Analysis. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. T...
May 2013
$4995
MediPoint: Breast Cancer Imaging - Current and Future Players
MediPoint: Breast Cancer Imaging Current and Future Players Summary Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption of western lif...
MediPoint: Breast Cancer Imaging Current and Future Players Summary Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption of western lif...
May 2013
$3500
Bisphenol A Industry Outlook in Asia Pacific to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Bisphenol A Industry Outlook in Asia Pacific to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Bisphenol A Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants...
Bisphenol A Industry Outlook in Asia Pacific to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Bisphenol A Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants...
May 2013
$3500
Bisphenol A Industry Outlook in Europe to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Bisphenol A Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Bisphenol A Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an...
Bisphenol A Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Bisphenol A Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an...
May 2013
$3500
Bisphenol A Industry Outlook in North America to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Bisphenol A Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Bisphenol A Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plan...
Bisphenol A Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Bisphenol A Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plan...
May 2013
$3500
Phenol Industry Outlook in Asia Pacific to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Phenol Industry Outlook in Asia Pacific to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Phenol Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides ...
Phenol Industry Outlook in Asia Pacific to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Phenol Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides ...
May 2013
$3500
Phenol Industry Outlook in Europe to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Phenol Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Phenol Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth ...
Phenol Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Phenol Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth ...
May 2013
$3500
Phenol Industry Outlook in North America to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Phenol Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Phenol Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provide...
Phenol Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Phenol Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provide...
May 2013
$3500
Acetone Industry Outlook in Asia Pacific to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Acetone Industry Outlook in Asia Pacific to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Acetone Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provide...
Acetone Industry Outlook in Asia Pacific to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Acetone Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provide...
May 2013
$3500
Acetone Industry Outlook in Europe to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Acetone Industry Outlook in Europe to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Acetone Industry Outlook to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-de...
Acetone Industry Outlook in Europe to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Acetone Industry Outlook to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-de...
May 2013
$3500
Acetone Industry Outlook in North America to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Acetone Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Acetone Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provi...
Acetone Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Acetone Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provi...
May 2013
$3500
Methanol Industry Outlook in Asia Pacific to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Methanol Industry Outlook in Asia Pacific to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Methanol Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provi...
Methanol Industry Outlook in Asia Pacific to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Methanol Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provi...
May 2013
$3500
Methanol Industry Outlook in Europe to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Methanol Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Methanol Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-de...
Methanol Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Methanol Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-de...
May 2013
$3500
Methanol Industry Outlook in North America to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Methanol Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Methanol Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants pro...
Methanol Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Methanol Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants pro...
May 2013
$3500
Expandable Polystyrene (EPS) Industry Outlook in Asia Pacific to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Expandable Polystyrene (EPS) Industry Outlook in Asia Pacific to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Expandable Polystyrene (EPS) Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecast...
Expandable Polystyrene (EPS) Industry Outlook in Asia Pacific to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Expandable Polystyrene (EPS) Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecast...
May 2013
$3500
Expandable Polystyrene (EPS) Industry Outlook in Europe to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Expandable Polystyrene (EPS) Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Expandable Polystyrene (EPS) Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Act...
Expandable Polystyrene (EPS) Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Expandable Polystyrene (EPS) Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Act...
May 2013
$3500
Expandable Polystyrene (EPS) Industry Outlook in North America to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Expandable Polystyrene (EPS) Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Expandable Polystyrene (EPS) Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Foreca...
Expandable Polystyrene (EPS) Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Expandable Polystyrene (EPS) Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Foreca...
May 2013
$3500
Acrylonitrile-Butadiene-Styrene (ABS) Industry Outlook in Asia Pacific to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Acrylonitrile-Butadiene-Styrene (ABS) Industry Outlook in Asia Pacific to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Acrylonitrile-Butadiene-Styrene (ABS) Industry Outlook to 2017 Market Size, Company Share, Pri...
Acrylonitrile-Butadiene-Styrene (ABS) Industry Outlook in Asia Pacific to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Acrylonitrile-Butadiene-Styrene (ABS) Industry Outlook to 2017 Market Size, Company Share, Pri...
May 2013
$3500
Acrylonitrile-Butadiene-Styrene (ABS) Industry Outlook in Europe to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Acrylonitrile-Butadiene-Styrene (ABS) Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Acrylonitrile Butadiene Styrene (ABS) Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Fo...
Acrylonitrile-Butadiene-Styrene (ABS) Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Acrylonitrile Butadiene Styrene (ABS) Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Fo...
May 2013
$3500
Acrylonitrile-Butadiene-Styrene (ABS) Industry Outlook in North America to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Acrylonitrile-Butadiene-Styrene (ABS) Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Acrylonitrile-Butadiene-Styrene (ABS) Industry Outlook to 2017 Market Size, Company Share, Pri...
Acrylonitrile-Butadiene-Styrene (ABS) Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Acrylonitrile-Butadiene-Styrene (ABS) Industry Outlook to 2017 Market Size, Company Share, Pri...
May 2013
$3500
Polycarbonate Industry Outlook in Asia Pacific to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Polycarbonate Industry Outlook in Asia Pacific to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Polycarbonate Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned ...
Polycarbonate Industry Outlook in Asia Pacific to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Polycarbonate Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned ...
May 2013
$3500
Polycarbonate Industry Outlook in Europe to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Polycarbonate Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Polycarbonate Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provide...
Polycarbonate Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Polycarbonate Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provide...
May 2013
$3500
Polycarbonate Industry Outlook in North America to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Polycarbonate Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Polycarbonate Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned ...
Polycarbonate Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Polycarbonate Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned ...
May 2013
$3500
Acrylonitrile Industry Outlook in Asia Pacific to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Acrylonitrile Industry Outlook in Asia Pacific to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Acrylonitrile Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants ...
Acrylonitrile Industry Outlook in Asia Pacific to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Acrylonitrile Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants ...
May 2013
$3500
Acrylonitrile Industry Outlook in Europe to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Acrylonitrile Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Acrylonitrile Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provide...
Acrylonitrile Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Acrylonitrile Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provide...
May 2013
$3500
Acrylonitrile Industry Outlook in North America to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Acrylonitrile Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Acrylonitrile Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned ...
Acrylonitrile Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Acrylonitrile Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned ...
May 2013
$3500
Polypropylene Industry Outlook in Asia Pacific to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Polypropylene Industry Outlook in Asia Pacific to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Polypropylene Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Pl...
Polypropylene Industry Outlook in Asia Pacific to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Asia Pacific Polypropylene Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Pl...
May 2013
$3500
Polypropylene Industry Outlook in Europe to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Polypropylene Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Polypropylene Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provide...
Polypropylene Industry Outlook in Europe to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Europe Polypropylene Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provide...
May 2013
$3500
Polypropylene Industry Outlook in North America to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Polypropylene Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Polypropylene Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and ...
Polypropylene Industry Outlook in North America to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, North America Polypropylene Industry Outlook to 2017 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and ...
May 2013
$3500
PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013
PharmaSphere: Global Biosimilars Strategy Regulatory Landscape, Key Drivers, Markets and Trends in 2013 Summary GlobalDatas "PharmaSphere: Global Biosimilars Strategy Regulatory Landscape, Key Drivers, Markets and Trends in 2013", provides strategic analysis of the global biosimilars industry. It discusses key market...
PharmaSphere: Global Biosimilars Strategy Regulatory Landscape, Key Drivers, Markets and Trends in 2013 Summary GlobalDatas "PharmaSphere: Global Biosimilars Strategy Regulatory Landscape, Key Drivers, Markets and Trends in 2013", provides strategic analysis of the global biosimilars industry. It discusses key market...
May 2013
$2995
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape US Summary GlobalData, the industry analysis specialist, has released its new report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape US. The report is an essential source of information and analysis on the healthcare, regulator...
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape US Summary GlobalData, the industry analysis specialist, has released its new report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape US. The report is an essential source of information and analysis on the healthcare, regulator...
May 2013
$1995
EpiCast Report: Asthma - Epidemiology Forecast to 2022
EpiCast Report: Asthma Epidemiology Forecast to 2022 Summary Asthma is one of the most common chronic diseases in the world, with an estimated 300 million people suffering from the disease in 2004 (Masoli et al., 2004). The 2004 Global Initiative for Asthma (GINA) report estimated that prevalence of asthma in the gen...
EpiCast Report: Asthma Epidemiology Forecast to 2022 Summary Asthma is one of the most common chronic diseases in the world, with an estimated 300 million people suffering from the disease in 2004 (Masoli et al., 2004). The 2004 Global Initiative for Asthma (GINA) report estimated that prevalence of asthma in the gen...
May 2013
$3995
MediPoint: Breast Cancer Imaging - US Analysis and Market Forecasts
MediPoint: Breast Cancer Imaging US Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption ...
MediPoint: Breast Cancer Imaging US Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption ...
May 2013
$4450
MediPoint: Breast Cancer Imaging - EU Analysis and Market Forecasts
MediPoint: Breast Cancer Imaging EU Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption of weste...
MediPoint: Breast Cancer Imaging EU Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption of weste...
May 2013
$4450
MediPoint: Breast Cancer Imaging - South America Analysis and Market Forecasts
MediPoint: Breast Cancer Imaging South America Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adopti...
MediPoint: Breast Cancer Imaging South America Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adopti...
May 2013
$4450
Japan Power Market Outlook to 2030 - Market Trends, Regulations and Competitive Landscape
Japan Power Market Outlook to 2030 Market Trends, Regulations and Competitive Landscape Summary This report gives detailed information on the Japan's power market. It examines the countrys power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed...
Japan Power Market Outlook to 2030 Market Trends, Regulations and Competitive Landscape Summary This report gives detailed information on the Japan's power market. It examines the countrys power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed...
May 2013
$1500
Cyprus Power Market Outlook to 2030 - Market Trends, Regulations and Competitive Landscape
Cyprus Power Market Outlook to 2030 Market Trends, Regulations and Competitive Landscape Summary This report gives detailed information on the Cyprus's power market. It examines the countrys power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030...
Cyprus Power Market Outlook to 2030 Market Trends, Regulations and Competitive Landscape Summary This report gives detailed information on the Cyprus's power market. It examines the countrys power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030...
May 2013
$1500
Slovakia Power Market Outlook to 2030 - Market Trends, Regulations and Competitive Landscape
Slovakia Power Market Outlook to 2030 Market Trends, Regulations and Competitive Landscape Summary This report gives detailed information on the Slovakia's power market. It examines the countrys power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. De...
Slovakia Power Market Outlook to 2030 Market Trends, Regulations and Competitive Landscape Summary This report gives detailed information on the Slovakia's power market. It examines the countrys power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. De...
May 2013
$1500
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape France Summary GlobalData, the industry analysis specialist, has released its new report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape France. The report is an essential source of information and an analysis on the healthcare, regula...
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape France Summary GlobalData, the industry analysis specialist, has released its new report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape France. The report is an essential source of information and an analysis on the healthcare, regula...
May 2013
$1995
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Italy Summary GlobalData, the industry analysis specialist, has released its new report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Italy. The report is an essential source of information and analysis on Italys healthcare, regulato...
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Italy Summary GlobalData, the industry analysis specialist, has released its new report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Italy. The report is an essential source of information and analysis on Italys healthcare, regulato...
May 2013
$1995
PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players
PharmaPoint: Chronic Myeloid Leukemia (CML) Current and Future Players Summary GlobalData has released its pharma report, PharmaPoint: Chronic Myeloid Leukemia (CML) Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing CML Ma...
PharmaPoint: Chronic Myeloid Leukemia (CML) Current and Future Players Summary GlobalData has released its pharma report, PharmaPoint: Chronic Myeloid Leukemia (CML) Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing CML Ma...
May 2013
$2995
Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
Gleevec (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Gleevec (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by...
Gleevec (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Gleevec (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by...
May 2013
$3495
Sprycel (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
Sprycel (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Sprycel (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is ch...
Sprycel (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Sprycel (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is ch...
May 2013
$3495
Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
Tasigna (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Tasigna (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by...
Tasigna (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Tasigna (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by...
May 2013
$3495
Bosulif (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
Bosulif (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Bosulif (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized ...
Bosulif (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Bosulif (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized ...
May 2013
$3495
Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
Iclusig (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Iclusig (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by...
Iclusig (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Iclusig (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by...
May 2013
$3495
Synribo (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
Synribo (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Synribo (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by...
Synribo (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Synribo (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by...
May 2013
$3495
EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022
EpiCast Report: Meningococcal Disease Epidemiology Forecast to 2022 Summary Meningococcal disease is caused by Neisseria meningitidis, which is an encapsulated, Gram-negative bacterium that has an incidence of one to three cases per 100,000 population worldwide (Giuliani et al., 2006). Strains of Neisseria meningitid...
EpiCast Report: Meningococcal Disease Epidemiology Forecast to 2022 Summary Meningococcal disease is caused by Neisseria meningitidis, which is an encapsulated, Gram-negative bacterium that has an incidence of one to three cases per 100,000 population worldwide (Giuliani et al., 2006). Strains of Neisseria meningitid...
May 2013
$3995
MediFocus: Medical Devices for the Treatment of Obesity
MediFocus: Medical Devices for the Treatment of Obesity Summary The obesity treatment market is drastically underserved and considerably underdeveloped. While bariatric surgery has significant improvement in recent decades, evolving to become the gold standard for proven treatment in the absence of effective pharmaco...
MediFocus: Medical Devices for the Treatment of Obesity Summary The obesity treatment market is drastically underserved and considerably underdeveloped. While bariatric surgery has significant improvement in recent decades, evolving to become the gold standard for proven treatment in the absence of effective pharmaco...
May 2013
$3995
Solar Trackers - Global Market Size, Average Price, Competitive Landscape and Key Country Analysis to 2020
Solar Trackers - Global Market Size, Average Price, Competitive Landscape and Key Country Analysis to 2020 Summary Solar Trackers - Global Market Size, Average Price, Competitive Landscape and Key Country Analysis to 2020 is the latest report from industry analysis specialists GlobalData, offering comprehensive informa...
Solar Trackers - Global Market Size, Average Price, Competitive Landscape and Key Country Analysis to 2020 Summary Solar Trackers - Global Market Size, Average Price, Competitive Landscape and Key Country Analysis to 2020 is the latest report from industry analysis specialists GlobalData, offering comprehensive informa...
May 2013
$3995
Oil and Gas Exploration and Production (E&P) in the Barents Sea - Market Analysis, Competitive Landscape and Production Forecasts to 2020
Oil and Gas Exploration and Production (E&P) in the Barents Sea - Market Analysis, Competitive Landscape and Production Forecasts to 2020 Summary Oil and Gas Exploration and Production (E&P) in the Barents Sea Market Analysis, Competitive Landscape and Production Forecasts to 2020, is the latest report from Glo...
Oil and Gas Exploration and Production (E&P) in the Barents Sea - Market Analysis, Competitive Landscape and Production Forecasts to 2020 Summary Oil and Gas Exploration and Production (E&P) in the Barents Sea Market Analysis, Competitive Landscape and Production Forecasts to 2020, is the latest report from Glo...
May 2013
$3995
Oil & Gas Exploration and Production in the Caspian Region, 2013 - Market Analysis, Competitive Landscape and Forecasts to 2020
Oil & Gas Exploration and Production in the Caspian Region, 2013 Market Analysis, Competitive Landscape and Forecasts to 2020 Summary Oil & Gas Exploration and Production in the Caspian Region, 2013 Market Analysis, Competitive Landscape and Forecasts to 2020, is the latest report from GlobalData, the industr...
Oil & Gas Exploration and Production in the Caspian Region, 2013 Market Analysis, Competitive Landscape and Forecasts to 2020 Summary Oil & Gas Exploration and Production in the Caspian Region, 2013 Market Analysis, Competitive Landscape and Forecasts to 2020, is the latest report from GlobalData, the industr...
May 2013
$3995
Nuclear Energy Quarterly Deals Analysis: M&A and Investment Trends Q1 2013
Nuclear Energy Quarterly Deals Analysis: M&A and Investment Trends Q1 2013 Summary GlobalData's Nuclear Energy Quarterly Deals Analysis: M&A and Investment Trends Q1 2013 report is a reliable source of essential data and analysis of mergers and acquisitions (M&As) and financing in the nuclear energy indus...
Nuclear Energy Quarterly Deals Analysis: M&A and Investment Trends Q1 2013 Summary GlobalData's Nuclear Energy Quarterly Deals Analysis: M&A and Investment Trends Q1 2013 report is a reliable source of essential data and analysis of mergers and acquisitions (M&As) and financing in the nuclear energy indus...
April 2013
$1500
Barnett Shale in the US, 2013 - Gas Shale Market Analysis and Forecasts to 2020
Barnett Shale in the US, 2013 Gas Shale Market Analysis and Forecasts to 2020 Summary GlobalData's new report "Barnett Shale in the US, 2013 Gas Shale Market Analysis and Forecasts to 2020" provides insight into the shale gas exploration and development potential of the Barnett play, including details of key exploration a...
Barnett Shale in the US, 2013 Gas Shale Market Analysis and Forecasts to 2020 Summary GlobalData's new report "Barnett Shale in the US, 2013 Gas Shale Market Analysis and Forecasts to 2020" provides insight into the shale gas exploration and development potential of the Barnett play, including details of key exploration a...
April 2013
$1500
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - Current and Future Players
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes Current and Future Players Summary Acute coronary syndrome (ACS) consists of two major diseases: myocardial infarction (MI) and unstable angina, with the former being one of the major killers in the mature markets. Though the incidence of ACS is ei...
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes Current and Future Players Summary Acute coronary syndrome (ACS) consists of two major diseases: myocardial infarction (MI) and unstable angina, with the former being one of the major killers in the mature markets. Though the incidence of ACS is ei...
April 2013
$3500
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - EU Analysis and Market Forecasts
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes EU Analysis and Market Forecasts Summary In Europe, the ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of high interest due to advancements in assay sensitivity both on laboratory...
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes EU Analysis and Market Forecasts Summary In Europe, the ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of high interest due to advancements in assay sensitivity both on laboratory...
April 2013
$4450
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - US Analysis and Market Forecasts
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes US Analysis and Market Forecasts Summary In the US, the ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of high interest due to advancements in assay sensitivity both on labor...
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes US Analysis and Market Forecasts Summary In the US, the ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of high interest due to advancements in assay sensitivity both on labor...
April 2013
$4450
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes APAC Analysis and Market Forecasts Summary The ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of high interest due to advancements in assay sensitivity both on laboratory and...
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes APAC Analysis and Market Forecasts Summary The ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of high interest due to advancements in assay sensitivity both on laboratory and...
April 2013
$4450
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - South America Analysis and Market Forecasts
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes South AmericaAnalysis and Market Forecasts Summary This report focuses on the Diagnostic Cardiac Biomarkers market in South America, principally Brazil. The ACS in vitro diagnostics market remains of high interest due to advancements in assay sensi...
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes South AmericaAnalysis and Market Forecasts Summary This report focuses on the Diagnostic Cardiac Biomarkers market in South America, principally Brazil. The ACS in vitro diagnostics market remains of high interest due to advancements in assay sensi...
April 2013
$4450
South Korea Power Market Outlook to 2030 - Market Trends, Regulations and Competitive Landscape
South Korea Power Market Outlook to 2030 Market Trends, Regulations and Competitive Landscape Summary This report gives detailed information on the South Korea's power market. It examines the countrys power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 20...
South Korea Power Market Outlook to 2030 Market Trends, Regulations and Competitive Landscape Summary This report gives detailed information on the South Korea's power market. It examines the countrys power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 20...
April 2013
$1500
Kazakhstan Power Market Outlook to 2030 - Market Trends, Regulations and Competitive Landscape
Kazakhstan Power Market Outlook to 2030 Market Trends, Regulations and Competitive Landscape Summary This report gives detailed information on the Kazakhstan's power market. It examines the countrys power market structure and provides historical and forecast numbers for generation, capacity and consumption up...
Kazakhstan Power Market Outlook to 2030 Market Trends, Regulations and Competitive Landscape Summary This report gives detailed information on the Kazakhstan's power market. It examines the countrys power market structure and provides historical and forecast numbers for generation, capacity and consumption up...
April 2013
$1500
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals Q1 2013
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals Q1 2013 Summary GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals Q1 2013 report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals Q1 2013 Summary GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals Q1 2013 report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (...
April 2013
$1500
PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022
Respiratory Syncytial Virus (RSV) Prophylactics US Drug Forecast and Market Analysis to 2022 Summary Respiratory syncytial virus (RSV) is a common cause of pediatric respiratory infections and virtually all children will have been infected by the virus by the age of two. RSV transmission typically occurs during the w...
Respiratory Syncytial Virus (RSV) Prophylactics US Drug Forecast and Market Analysis to 2022 Summary Respiratory syncytial virus (RSV) is a common cause of pediatric respiratory infections and virtually all children will have been infected by the virus by the age of two. RSV transmission typically occurs during the w...
April 2013
$4995
PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - Current and Future Players
PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics Current and Future Players Summary GlobalData has released its pharma report, PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics Current and Future Players. The report is a vital source of up-to-date information with in-depth a...
PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics Current and Future Players Summary GlobalData has released its pharma report, PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics Current and Future Players. The report is a vital source of up-to-date information with in-depth a...
April 2013
$2995
PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022
PharmaPoint: Chronic Myeloid Leukemia (CML) United States Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) United States Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative b...
PharmaPoint: Chronic Myeloid Leukemia (CML) United States Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) United States Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative b...
April 2013
$4995
PharmaPoint: Chronic Myeloid Leukemia (CML) - France Drug Forecast and Market Analysis to 2022
PharmaPoint: Chronic Myeloid Leukemia (CML) France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) France Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer th...
PharmaPoint: Chronic Myeloid Leukemia (CML) France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) France Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer th...
April 2013
$4995
PharmaPoint: Chronic Myeloid Leukemia (CML) - Germany Drug Forecast and Market Analysis to 2022
PharmaPoint: Chronic Myeloid Leukemia (CML) Germany Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) Germany Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer ...
PharmaPoint: Chronic Myeloid Leukemia (CML) Germany Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) Germany Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer ...
April 2013
$4995
PharmaPoint: Chronic Myeloid Leukemia (CML) - Italy Drug Forecast and Market Analysis to 2022
PharmaPoint: Chronic Myeloid Leukemia (CML) Italy Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) Italy Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that...
PharmaPoint: Chronic Myeloid Leukemia (CML) Italy Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) Italy Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that...
April 2013
$4995
PharmaPoint: Chronic Myeloid Leukemia (CML) - Spain Drug Forecast and Market Analysis to 2022
PharmaPoint: Chronic Myeloid Leukemia (CML) Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) Spain Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that...
PharmaPoint: Chronic Myeloid Leukemia (CML) Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) Spain Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that...
April 2013
$4995
PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022
PharmaPoint: Chronic Myeloid Leukemia (CML) United Kingdom Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) United Kingdom Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproli...
PharmaPoint: Chronic Myeloid Leukemia (CML) United Kingdom Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) United Kingdom Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproli...
April 2013
$4995
PharmaPoint: Chronic Myeloid Leukemia (CML) - Japan Drug Forecast and Market Analysis to 2022
PharmaPoint: Chronic Myeloid Leukemia (CML) Japan Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) Japan Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that...
PharmaPoint: Chronic Myeloid Leukemia (CML) Japan Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) Japan Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that...
April 2013
$4995
Synagis (Pediatric RSV) - Forecast and Market Analysis to 2022
Synagis (Pediatric RSV) Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Synagis (Pediatric RSV) Forecast and Market Analysis to 2022. Respiratory syncytial virus (RSV) is a common cause of pediatric respiratory infections and virtually all children will...
Synagis (Pediatric RSV) Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Synagis (Pediatric RSV) Forecast and Market Analysis to 2022. Respiratory syncytial virus (RSV) is a common cause of pediatric respiratory infections and virtually all children will...
April 2013
$3495
Ascites Global Clinical Trials Review, H1, 2013
Ascites Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Ascites Global Clinical Trials Review, H1, 2013" provides data on the Ascites clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ascites. It includes an overview of ...
Ascites Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Ascites Global Clinical Trials Review, H1, 2013" provides data on the Ascites clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ascites. It includes an overview of ...
April 2013
$2500
Cancer Pain Global Clinical Trials Review, H1, 2013
Cancer Pain Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Cancer Pain Global Clinical Trials Review, H1, 2013" provides data on the Cancer Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cancer Pain. It includes...
Cancer Pain Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Cancer Pain Global Clinical Trials Review, H1, 2013" provides data on the Cancer Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cancer Pain. It includes...
April 2013
$2500
Inflammatory Pain Global Clinical Trials Review, H1, 2013
Inflammatory Pain Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Inflammatory Pain Global Clinical Trials Review, H1, 2013" provides data on the Inflammatory Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inflam...
Inflammatory Pain Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Inflammatory Pain Global Clinical Trials Review, H1, 2013" provides data on the Inflammatory Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inflam...
April 2013
$2500
MediPoint: Peripheral Vascular Stents for the Lower Extremity - Current and Future Players
MediPoint: Peripheral Vascular Stents for the Lower Extremity Current and Future Players Summary GlobalData has released its medical devices report, MediPoint: Peripheral Vascular Stents for the Lower Extremity Current and Future Players. The report is an essential source of information and analysis on the global Per...
MediPoint: Peripheral Vascular Stents for the Lower Extremity Current and Future Players Summary GlobalData has released its medical devices report, MediPoint: Peripheral Vascular Stents for the Lower Extremity Current and Future Players. The report is an essential source of information and analysis on the global Per...
April 2013
$3500
MediPoint: Peripheral Vascular Stents for the Lower Extremity - EU Analysis and Market Forecasts
MediPoint: Peripheral Vascular Stents for the Lower Extremity EU Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorba...
MediPoint: Peripheral Vascular Stents for the Lower Extremity EU Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorba...
April 2013
$4450
MediPoint: Peripheral Vascular Stents for the Lower Extremity - South America Analysis and Market Forecasts
MediPoint: Peripheral Vascular Stents for the Lower Extremity South America Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and...
MediPoint: Peripheral Vascular Stents for the Lower Extremity South America Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and...
April 2013
$4450
MediPoint: Peripheral Vascular Stents for the Lower Extremity - APAC Analysis and Market Forecasts
MediPoint: Peripheral Vascular Stents for the Lower Extremity APAC Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsor...
MediPoint: Peripheral Vascular Stents for the Lower Extremity APAC Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsor...
April 2013
$4450
MediPoint: Peripheral Vascular Stents for the Lower Extremity - US Analysis and Market Forecasts
MediPoint: Peripheral Vascular Stents for the Lower Extremity US Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorba...
MediPoint: Peripheral Vascular Stents for the Lower Extremity US Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorba...
April 2013
$4450
